Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 26,045,000 | 16,204,000 | 13,544,000 | 12,504,000 | 11,306,000 |
| Cost of Goods | 3,755,000 | 2,528,000 | 2,094,000 | 2,274,000 | 2,176,000 |
| Gross Profit | 22,290,000 | 13,676,000 | 11,450,000 | 10,230,000 | 9,130,000 |
| Operating Expenses | 17,163,000 | 9,127,000 | 7,847,000 | 6,884,000 | 6,326,000 |
| Operating Income | 5,127,000 | 4,549,000 | 3,603,000 | 3,346,000 | 2,804,000 |
| Other Income | 374,000 | -101,000 | -1,009,000 | -258,000 | 0 |
| Pre-tax Income | 5,501,000 | 4,448,000 | 2,594,000 | 3,088,000 | 2,804,000 |
| Income Tax | 1,946,000 | 1,244,000 | 642,000 | 865,000 | 869,000 |
| Net Income Continuous | 3,542,000 | 3,404,000 | 2,630,000 | 2,082,000 | 1,929,000 |
| Net Income Discontinuous | 184,000 | -20,000 | 1,401,000 | 0 | 0 |
| Net Income | $3,726,000 | $3,179,000 | $3,351,000 | $2,213,000 | $1,929,000 |
| EPS Basic Total Ops | 0.60 | 0.84 | 0.88 | 0.59 | 0.50 |
| EPS Basic Continuous Ops | 0.57 | 0.90 | 0.69 | 0.55 | 0.50 |
| EPS Basic Discontinuous Ops | 0.03 | -0.01 | 0.37 | N/A | N/A |
| EPS Diluted Total Ops | 0.59 | 0.82 | 0.49 | 0.57 | 0.50 |
| EPS Diluted Continuous Ops | 0.56 | 0.88 | 0.67 | 0.53 | 0.50 |
| EPS Diluted Discontinuous Ops | 0.03 | -0.01 | 0.36 | N/A | N/A |
| EBITDA(a) | $6,006,000 | $5,091,000 | $4,092,000 | $3,848,000 | $3,234,000 |